explore -WSS

explore

author：explore 2025-09-03 03:25:59 - browse：53

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： MultiPlan and major insurers sued for alleged medical price

focus

WSS

After traumatic brain injury, life support decisions can use more time

Health care needs a new profession: neuroimaging counseling

STAT Executive Editor Rick Berke on STAT's 8th birthday

Bird flu outbreak in cows is latest avian flu curveball

Q&A: Jennifer Adair on making gene therapy available globally

Cholera vaccine supply gets boost as demand surges globally

entertainment

explore

knowledge

Medical leaders decry Supreme Court decision on affirmative action

FTC falls short on scrutinizing hospital mergers, study says

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth financials solid despite Change Healthcare cyberattack

Novavax promises a turnaround & Lilly roils the obesity market

UnitedHealth financials solid despite Change Healthcare cyberattack

Continuity nursing helped my family in our darkest PICU moments

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

The high cost of giving birth even with insurance

Just how powerful is the placebo effect?

focus

UnitedHealth financials solid despite Change Healthcare cyberattack

MoonLake credibility takes another hit with mid

Element Biosciences CEO lays out genome sequencing strategy

HPV cancer vaccine study demonstrates efficacy

Extreme heat events are a public health emergency

Excited delirium, Elijah McClain, and emergency physicians

hotspot

focus

hotspot

knowledge